QQ客服 官方微博 反馈留言

	Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial
	Jukema, J. Wouter; Szarek, Michael; Zijlstra, Laurien E.; de Silva, H. Asita; Bhatt, Deepak L.; Bittner, Vera A.; Diaz, Rafael; Edelberg 更多
刊名	JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
	2019
卷号	74期号:9页码:1167-1176
关键词	acute coronary syndrome alirocumab cerebrovascular disease death major adverse cardiac events peripheral artery disease
DOI	10.1016/j.jacc.2019.03.013
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4550880
专题	山东大学
作者单位	1.Leiden Univ, Dept Cardiol, Med Ctr, POB 9600, NL-2300 RC Leiden, Netherlands. 2.SUNY, Dow
推荐引用方式 GB/T 7714	Jukema, J. Wouter,Szarek, Michael,Zijlstra, Laurien E.,et al. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,2019,74(9):1167-1176.
APA	Jukema, J. Wouter.,Szarek, Michael.,Zijlstra, Laurien E..,de Silva, H. Asita.,Bhatt, Deepak L..,...&Edelberg 更多.(2019).Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,74(9),1167-1176.
MLA	Jukema, J. Wouter,et al."Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial".JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 74.9(2019):1167-1176.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。